Menu
GeneBe

rs117667651

Variant summary

Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS1

The NM_001378615.1(CC2D2A):c.4438-9C>A variant causes a splice polypyrimidine tract, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000506 in 1,546,552 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.00051 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00051 ( 2 hom. )

Consequence

CC2D2A
NM_001378615.1 splice_polypyrimidine_tract, intron

Scores

2
Splicing: ADA: 0.005747
2

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:3B:4

Conservation

PhyloP100: 1.02
Variant links:
Genes affected
CC2D2A (HGNC:29253): (coiled-coil and C2 domain containing 2A) This gene encodes a coiled-coil and calcium binding domain protein that appears to play a critical role in cilia formation. Mutations in this gene cause Meckel syndrome type 6, as well as Joubert syndrome type 9. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Sep 2009]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -9 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.79).
BP6
Variant 4-15597398-C-A is Benign according to our data. Variant chr4-15597398-C-A is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 238279.We mark this variant Likely_benign, oryginal submissions are: {Benign=2, Likely_benign=2, Uncertain_significance=3}. Variant chr4-15597398-C-A is described in Lovd as [Likely_benign].
BS1
Variant frequency is greater than expected in population eas. gnomad4_exome allele frequency = 0.000506 (706/1394330) while in subpopulation EAS AF= 0.0128 (458/35760). AF 95% confidence interval is 0.0118. There are 2 homozygotes in gnomad4_exome. There are 366 alleles in male gnomad4_exome subpopulation. Median coverage is 29. This position pass quality control queck.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
CC2D2ANM_001378615.1 linkuse as main transcriptc.4438-9C>A splice_polypyrimidine_tract_variant, intron_variant ENST00000424120.6
CC2D2ANM_001080522.2 linkuse as main transcriptc.4438-9C>A splice_polypyrimidine_tract_variant, intron_variant
CC2D2ANM_001378617.1 linkuse as main transcriptc.4291-9C>A splice_polypyrimidine_tract_variant, intron_variant

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
CC2D2AENST00000424120.6 linkuse as main transcriptc.4438-9C>A splice_polypyrimidine_tract_variant, intron_variant 5 NM_001378615.1 P1Q9P2K1-4

Frequencies

GnomAD3 genomes
AF:
0.000506
AC:
77
AN:
152104
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000241
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00157
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00808
Gnomad SAS
AF:
0.00145
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.000956
GnomAD3 exomes
AF:
0.00141
AC:
220
AN:
156338
Hom.:
0
AF XY:
0.00142
AC XY:
117
AN XY:
82358
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00430
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00953
Gnomad SAS exome
AF:
0.000362
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000163
Gnomad OTH exome
AF:
0.000686
GnomAD4 exome
AF:
0.000506
AC:
706
AN:
1394330
Hom.:
2
Cov.:
29
AF XY:
0.000532
AC XY:
366
AN XY:
687850
show subpopulations
Gnomad4 AFR exome
AF:
0.0000319
Gnomad4 AMR exome
AF:
0.00413
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.0128
Gnomad4 SAS exome
AF:
0.000740
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00000558
Gnomad4 OTH exome
AF:
0.000657
GnomAD4 genome
AF:
0.000506
AC:
77
AN:
152222
Hom.:
0
Cov.:
32
AF XY:
0.000699
AC XY:
52
AN XY:
74428
show subpopulations
Gnomad4 AFR
AF:
0.0000241
Gnomad4 AMR
AF:
0.00157
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00810
Gnomad4 SAS
AF:
0.00145
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000147
Gnomad4 OTH
AF:
0.000946
Alfa
AF:
0.000214
Hom.:
0
Bravo
AF:
0.000865
Asia WGS
AF:
0.00404
AC:
14
AN:
3478

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:3Benign:4
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not specified Uncertain:1Benign:1
Benign, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Feb 01, 2016- -
Uncertain significance, criteria provided, single submitterclinical testingWomen's Health and Genetics/Laboratory Corporation of America, LabCorpNov 27, 2022Variant summary: CC2D2A c.4438-9C>A alters a non-conserved nucleotide located close to a canonical splice site and therefore could affect mRNA splicing, leading to a significantly altered protein sequence. 4/4 computational tools predict no significant impact on normal splicing. However, these predictions have yet to be confirmed by functional studies. The variant allele was found at a frequency of 0.0014 in 156338 control chromosomes (gnomAD), predominantly at a frequency of 0.0095 within the East Asian subpopulation in the gnomAD database. To our knowledge, no occurrence of c.4438-9C>A in individuals affected with CC2D2A-Related Disorders and no experimental evidence demonstrating its impact on protein function have been reported. Four ClinVar submitters have assessed the variant since 2014: one classified the variant as uncertain significance, two as likely benign, and one as benign. Based on the evidence outlined above, the variant was classified as uncertain significance. -
Meckel syndrome, type 6 Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 12, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. -
Joubert syndrome 9 Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 12, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. -
Meckel-Gruber syndrome;C0431399:Familial aplasia of the vermis Benign:1
Likely benign, criteria provided, single submitterclinical testingInvitaeJan 31, 2024- -
not provided Benign:1
Likely benign, criteria provided, single submitterclinical testingGeneDxJan 30, 2021- -
CC2D2A-related disorder Benign:1
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact SciencesJul 17, 2019This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.79
Cadd
Benign
13
Dann
Benign
0.46

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.0057
dbscSNV1_RF
Benign
0.046
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs117667651; hg19: chr4-15599021; API